Torrent Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

169.23

84.62

84.62

84.62

84.62

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6,286.73

6,260.80

5,945.48

5,036.35

4,930.65

Loan funds

Secured loans

4,565.56

3,343.41

4,384.43

3,913.76

4,466.59

Unsecured loans

-

-

-

-

-

Total

11,021.52

9,688.83

10,414.53

9,034.73

9,481.86

Uses of funds

Fixed assets

Gross block

9,693.59

7,794.90

8,135.03

8,386.11

8,442.29

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,721.74

1,543.65

1,393.79

1,188.61

1,017.14

Net block

7,971.85

6,251.25

6,741.24

7,197.50

7,425.15

Capital work-in-progress

697.93

567.50

588.11

536.41

497.58

Investments

361.21

367.64

313.92

134.89

486.22

Net current assets

Current assets, loans & advances

3,840.94

3,966.17

4,117.77

4,015.67

3,618.32

Less : current liabilities & provisions

1,850.41

1,463.73

1,346.51

2,849.74

2,545.41

Total net current assets

1,990.53

2,502.44

2,771.26

1,165.93

1,072.91

Miscellaneous expenses not written

-

-

-

-

-

Total

11,021.52

9,688.83

10,414.53

9,034.73

9,481.86

Notes:

Book value of unquoted investments

361.18

367.64

313.92

134.87

486.22

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1,448.95

1,296.42

1,155.38

325.37

374.94

Number of equity sharesoutstanding (Lacs)

3384.45

1692.23

1692.23

1692.23

1692.23